SelectSecure™ Model 3830 pacing lead is for pacing and sensing in the atrium or right ventricle, also at the bundle of His or left bundle branch area.
Medtronic SelectSecure™ family of leads has application where implantable atrial or ventricular, single-chamber or dual-chamber pacing systems are indicated. The Model 3830 lead is intended for pacing and sensing in the atrium or ventricle.
Medtronic SelectSecure™ MRI family of leads is intended for pacing and sensing in the atrium or right ventricle. It is also intended for pacing and sensing at the bundle of His or in the left bundle branch area as an alternative to right ventricular pacing in a single or dual chamber pacing system.
SelectSecure™ MRI SureScan™ leads (specified lengths of Model 3830 including 59, 69 and 74 cm) are MR Conditional and indicated for pacing and sensing at the bundle of His or in the left bundle branch area as an alternative to right ventricular pacing in a single or dual chamber pacing system. The Model 3830 lead is part of the Medtronic SureScan™ system. The SureScan™ system includes a Medtronic SureScan™ device connected to Medtronic SureScan™ leads.
SelectSecure™ lead family is contraindicated for the following:
The SelectSecure™ Model 3830 lead is also contraindicated for patients with obstructed or inadequate vasculature for intravenous catheterization.
People with metal implants such as pacemakers, implantable cardioverter defibrillators (ICDs) and accompanying leads should not receive certain forms of diathermy treatment. Diathermy treatments may result in serious injury or damage to an implanted device and lead system. Some lead models allow the use of therapeutic ultrasound; consult individual lead model technical manuals for more detail.
For Model 3830, total patient exposure to beclomethasone 17,21-dipropionate should be considered when implanting multiple leads. No drug interactions with inhaled beclomethasone 17,21-dipropionate have been described. Drug interactions of beclomethasone 17,21-dipropionate with the Model 3830 lead have not been studied.
Do not use magnetic resonance imaging (MRI) on patients who have non-MR Conditional versions/lengths of these leads implanted as part of a complete SureScan™ system. MRI can induce currents on implanted leads, potentially causing tissue damage and the induction of tachyarrhythmias.
MRI SureScan™ leads only: A complete SureScan™ pacing or defibrillation system is required for use in the MR environment. Before performing an MRI scan, refer to the MRI technical manual for MRI-specific warnings and precautions. Patients and their implanted systems must be screened to meet the following requirements for MRI: no implanted lead extenders, lead adaptors, or abandoned leads; no broken leads or leads with intermittent electrical contact as confirmed by lead impedance history; a SureScan™ defibrillation system implanted in the left or right pectoral region; pacing capture thresholds of ≤ 2.0 V at a pulse width of 0.4 ms; no diaphragmatic stimulation at a pacing output of 5.0 V and at a pulse width of 1.0 ms in patients whose device will be programmed to an asynchronous pacing mode when MRI SureScan™ is programmed to ”on.. Patients may be scanned using a horizontal field, cylindrical bore, clinical 1.5T or 3T MRI system for hydrogen proton imaging.
Potential patient-related complications related to the use of transvenous leads include, but are not limited to, valve damage, fibrillation and other arrhythmias, thrombolytic and air embolism, cardiac perforation, heart wall rupture, cardiac tamponade, muscle or nerve stimulation, pericarditis, pericardial rub, infection, myocardial irritability, thrombosis and pneumothorax. Other potential lead-related complications may include exit block, lead dislodgement, lead fracture, insulation failure, and threshold elevation.
Potential MRI complications include, but are not limited to, lead electrode heating and tissue damage resulting in loss of sensing or capture or both, or induced currents on leads resulting in continuous capture, VT/VF, and/or hemodynamic collapse.
See the appropriate Device MRI SureScan™ technical manual before performing an MRI scan and lead technical manual for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 1-800-328-2518 and/or consult the Medtronic website.
Caution: Federal law (United States) restricts this device to sale by or on the order of a physician.
Rev 10/22
MAJ_90561
Find more information, including other available configurations, for SelectSecure™ pacing lead.
Your information will be used and protected in accordance with our {link}
Hours: 8:00 a.m. - 8:00 p.m. EST
Phone: 763-514-4000
Toll-free: 800-633-8766
Just to confirm, is this the product or product type that interests you?
{{productNamePlaceholder}}
OR
Before we get started, what best describes you?
If you subscribe to email updates, you can unsubscribe anytime via the link in each email. We use technology to measure email opens and clicks, to improve our communications and provide relevant content. For details, see our {link}
Your personal data will be used to manage your relationship with Medtronic in accordance with our {link}
If you consent to receive emails, you can unsubscribe anytime via the link in each email. We use technology that measures email opens and clicks, to improve our communications and provide relevant content. For details, see our {link}
